Multivariate analysis: predictors of retreatment for 398 unruptured aneurysms
| Parameter | Follow-Up | |||
|---|---|---|---|---|
| 455 Days | 820 Days | |||
| OR (95% CI) | P Value | OR (95% CI) | P Value | |
| Dome size (≥10 mm vs <10 mm) | 4.12 (1.19–14.2) | .0253 | 5.28 (1.58–17.7) | .0071 |
| Neuroforma used at index 1 vs 0 | 0.54 (0.20–1.44) | .2142 | 0.49 (0.19–1.23) | .1269 |
| Neck size (≥4 mm vs <4 mm) | 1.39 (0.47–4.13) | .5470 | 1.85 (0.71–4.83) | .2068 |
| North America 1 vs 0 | 2.22 (0.69–7.14) | .1788 | 1.53 (0.57–4.08) | .3973 |
| Core laboratory postprocedure Raymond scale 2 vs 1 | 1.13 (0.24–5.39) | .8759 | 0.79 (0.21–2.97) | .7313 |
| Core laboratory postprocedure Raymond scale 3 vs 1 | 3.62 (1.06–12.4) | .0405 | 2.31 (0.84–6.38) | .1056 |
| Aneurysm size (<10 mm vs ≥10 mm) | 0.40 (0.11–1.42) | .1576 | 0.62 (0.19–1.99) | .4212 |
Note:—OR indicates odds ratio.
↵a Stryker Neurovascular, Kalamazoo, Michigan.